Emma Clayton: Emma Clayton, Managing Director, Grey Bear Consultancy, tells all about Women in Healthcare and how the future is shaping up for women leaders in the NHS?

The future for women leaders in the NHS

Emma Clayton, Managing Director, Grey Bear Consultancy, tells all about Women in Healthcare and how the future is shaping up for women leaders in...
New figures on cancer survival in the UK

New figures on cancer survival in the UK

Cancer survival in the UK has improved since 1995, but still lags behind other high-income countries, according to new analysis by the International Cancer...
Dependence on prescription medicines uncovered in Public Health England review

Dependence on prescription medicines uncovered in Public Health England review

A Public Health England review of prescribed medicines has linked dependence on prescription medicines to deprivation. Public Health England has published the first-ever evidence review...
Customer Behaviour: In-depth knowledge on the fast-changing NHSIn-depth knowledge on the fast-changing NHS

Is in-depth knowledge of the NHS essential to your career?

Oli Hudson, Content Director and John Chater, Solutions Director in Education and Training, at Wilmington Healthcare explain how an in-depth knowledge of the fast-changing...
No deal Brexit and the NHS: A health service on the brink

No deal Brexit and the NHS: A health service on the brink

The BMA has published a new report on the dangers of a no deal Brexit and the NHS. The BMA has repeatedly warned that...
New analyses of the worldwide epidemiological evidence demonstrate link between HRT and breast cancer incidence, and find that some risk persists.

New research into link between HRT and breast cancer

New analyses of the worldwide epidemiological evidence demonstrate link between HRT and breast cancer incidence, and find that some risk persists for many years. An...
A wearable sensor is being used to study cancer-related fatigue in patients with breast cancer

Cognitant and UCB deliver immersive VR programme at Addenbrooke’s Hospital

Cognitant Group and UCB have introduced a new programme that provides health information in the form of visual and immersive experiences.This new technology will...
The first medically approved back pain app launches in the EU and UK with the aim to end the nationwide epidemic of back pain in UK offices

First medically approved back pain app launches in EU and UK

The first medically approved back pain app launches in the EU and UK with the aim to end the nationwide epidemic of back pain...
NICE publishes updated guideline on diagnosis and treatment of hypertension

NICE publishes updated guideline on diagnosis and treatment of hypertension

NICE has issued its final updated guideline on the diagnosis and treatment of hypertension. The final guideline, published by the National Institute for Health and...
women standing in a group depicting a new report on supporting women with cancer

Breaking the taboo around HRT

Hormone replacement therapy (HRT) has been battling perceptions of its safety reputation for over 15 years. But for people going through menopause, it can...

Latest articles

Image of four people communicating via different mediums to depict mind the Generation Gap in pharma marketing

Mind the Generation Gap in pharma marketing and market research

Industry came together to explore the impact of the generation gap in pharma marketing and market research at BHBIA's summer event. Different generations have always...
AstraZeneca presents results from Phase III TULIP 2 trial for anifrolumab

AstraZeneca presents anifrolumab results from Phase III TULIP trial

Results from the positive Phase III TULIP 2 trial for AstraZeneca's anifrolumab, a potential new medicine for the treatment of moderate to severe systemic...
Scottish flag showing Novartis advanced breast cancer treatment approved in Scotland

Novartis advanced breast cancer treatment approved in Scotland

Novartis’ Kisqali® (ribociclib) in combination with fulvestrant receives recommendation from Scottish Medicines Consortium as advanced breast cancer treatment for patients with the most common...

Popular articles

People sitting around a desk with laptops and tablets to show NHS Commercial Framework for Medicines published for consultation

NHS Commercial Framework for Medicines consultation published

NHS England has published the NHS Commercial Framework for Medicines for consultation. NHS England has a significant role to play in supporting patient access to...
Mapping NHS change is key to customer engagement

Mapping NHS change is key to customer engagement

Simon Grime, of Wilmington Healthcare, explains how mapping NHS change through data and intelligence can help industry understand and engage customers in the new...
Pharmafield logo in lightbulb: Pf Power List 2019

Pf Power List 2019: Who is shaping the pharma & healthcare sector?

The Pf Power List has looked at who is making a difference in pharma and healthcare in 2019. This year has brought a range of developments...
Scottish flag showing Novartis advanced breast cancer treatment approved in Scotland

Novartis advanced breast cancer treatment approved in Scotland

Novartis’ Kisqali® (ribociclib) in combination with fulvestrant receives recommendation from Scottish Medicines Consortium as advanced breast cancer treatment for patients with the most common...
Image of a head with squiggly lines in the brain and cogs on top to indicate Medopad and Janssen collaborate on novel digital biomarker for Alzheimer's disease

Medopad and Janssen collaborate on novel digital biomarker for Alzheimer’s disease

Medopad has announced a strategic collaboration with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to validate, scale and...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription